Literature DB >> 26124160

Preliminary method for direct quantification of colistin methanesulfonate by attenuated total reflectance Fourier transform infrared spectroscopy.

Krista L Niece1, Kevin S Akers2.   

Abstract

Colistin use has increased in response to the advent of infections caused by multidrug-resistant organisms. It is administered parenterally as an inactive prodrug, colistin methanesulfonate (CMS). Various formulations of CMS and labeling conventions can lead to confusion about colistin dosing, and questions remain about the pharmacokinetics of CMS. Since CMS does not have strong UV absorbance, current methods employ a laborious process of chemical conversion to colistin followed by precolumn derivatization to detect formed colistin by high-performance liquid chromatography. Here, we report a method for direct quantification of colistin methanesulfonate by attenuated total reflectance Fourier transform infrared spectroscopy (ATR FTIR).
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26124160      PMCID： PMC4538559          DOI： 10.1128/AAC.00805-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  28 in total

1.  A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography.

Authors:  J Li; R W Milne; R L Nation; J D Turnidge; K Coulthard; D W Johnson
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-09-25

2.  Application of attenuated total reflectance Fourier transform infrared spectroscopy for determination of cefixime in oral pharmaceutical formulations.

Authors:  Aftab A Kandhro; Abdul Hafeez Laghari; Sarfaraz A Mahesar; Rubina Saleem; Aisha Nelofar; Salman Tariq Khan; S T H Sherazi
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2013-06-19       Impact factor: 4.098

3.  Pharmacokinetics of four different brands of colistimethate and formed colistin in rats.

Authors:  Hui He; Ji-Chang Li; Roger L Nation; Jovan Jacob; Gong Chen; Hee Ji Lee; Brian T Tsuji; Philip E Thompson; Kade Roberts; Tony Velkov; Jian Li
Journal:  J Antimicrob Chemother       Date:  2013-06-07       Impact factor: 5.790

4.  Consistent global approach on reporting of colistin doses to promote safe and effective use.

Authors:  Roger L Nation; Jian Li; Otto Cars; William Couet; Michael N Dudley; Keith S Kaye; Johan W Mouton; David L Paterson; Vincent H Tam; Ursula Theuretzbacher; Brian T Tsuji; John D Turnidge
Journal:  Clin Infect Dis       Date:  2013-10-08       Impact factor: 9.079

Review 5.  Colistin: an update on the antibiotic of the 21st century.

Authors:  Silpak Biswas; Jean-Michel Brunel; Jean-Christophe Dubus; Martine Reynaud-Gaubert; Jean-Marc Rolain
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

6.  Variability within investigations of intravenous colistin: the scope of the problem.

Authors:  Timothy P Gauthier; Evan Lantz; Corey Frederick; Hoda Masmouei; Larisa Ruiz-Serrano; Laura Smith; William R Wolowich; Lilian M Abbo
Journal:  Clin Infect Dis       Date:  2014-01-26       Impact factor: 9.079

7.  Quantitative Fourier transform-infrared/attenuated total reflectance (FT-IR/ATR) analysis of trimethoprim and sulfamethoxazole in a pharmaceutical formulation using partial least squares.

Authors:  K J Hartauer; J K Guillory
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

8.  Determination of colistin A and colistin B in human plasma by UPLC-ESI high resolution tandem MS: application to a pharmacokinetic study.

Authors:  Evangelos Gikas; Fotini N Bazoti; Marina Katsimardou; Dimitrios Anagnostopoulos; Konstantinos Papanikolaou; Ilias Inglezos; Athanasios Skoutelis; Georgios L Daikos; Anthony Tsarbopoulos
Journal:  J Pharm Biomed Anal       Date:  2013-05-16       Impact factor: 3.935

9.  Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Kingsley Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard
Journal:  J Antimicrob Chemother       Date:  2004-03-24       Impact factor: 5.790
View more
  1 in total

Review 1.  An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection.

Authors:  Tatiana Pacheco; Rosa-Helena Bustos; Diana González; Vivian Garzón; Julio-Cesar García; Daniela Ramírez
Journal:  Antibiotics (Basel)       Date:  2019-07-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.